Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity.
Wiley LK, Moretz JD, Denny JC, Peterson JF, Bush WS. Wiley LK, et al. AMIA Jt Summits Transl Sci Proc. 2015 Mar 25;2015:466-70. eCollection 2015. AMIA Jt Summits Transl Sci Proc. 2015. PMID: 26306287 Free PMC article.
It is unclear the extent to which best practices for phenotyping disease states from electronic medical records (EMRs) translate to phenotyping adverse drug events. ...We conclude that phenotype algorithms for adverse drug events s …
It is unclear the extent to which best practices for phenotyping disease states from electronic medical records (EMRs) translate to …
Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
Lu B, Sun L, Seraydarian M, Hoffmann TJ, Medina MW, Risch N, Iribarren C, Krauss RM, Oni-Orisan A. Lu B, et al. Clin Pharmacol Ther. 2021 Sep;110(3):733-740. doi: 10.1002/cpt.2337. Epub 2021 Jul 23. Clin Pharmacol Ther. 2021. PMID: 34114646
The aim of this study was to investigate the relationship between rs4149056 genotype and statin-induced myotoxicity in patients taking atorvastatin and lovastatin. ...To validate the drug response phenotype, we replicated the previously established ass …
The aim of this study was to investigate the relationship between rs4149056 genotype and statin-induced myotoxicity in patient …